Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon

SIMPLE SUMMARY: Although effective in the majority of patients, the progression-free survival (PFS) to imatinib treatment can vary widely in effectiveness. Based on the known predictive role of tyrosine kinase (KIT) and platelet-derived growth factor receptor α (PDGRA) tumor genotypes, the different...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Cancers (Basel)
Main Authors:	Incorvaia, Lorena, Fanale, Daniele, Vincenzi, Bruno, De Luca, Ida, Bartolotta, Tommaso Vincenzo, Cannella, Roberto, Pantuso, Gianni, Cabibi, Daniela, Russo, Antonio, Bazan, Viviana, Badalamenti, Giuseppe
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI 2021
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7956844/ https://ncbi.nlm.nih.gov/pubmed/33673554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13050993
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon

Lignende værker